Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
Review

Beyond depression: Other uses for tricyclic antidepressants

Joanne Schneider, DNP, RN, CNP, Mary Patterson, CNP and Xavier F. Jimenez, MD, MA
Cleveland Clinic Journal of Medicine December 2019, 86 (12) 807-814; DOI: https://doi.org/10.3949/ccjm.86a.19005
Joanne Schneider
Center for Comprehensive Pain Recovery, Neurological Institute, Cleveland Clinic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary Patterson
Center for Comprehensive Pain Recovery, Neurological Institute, Cleveland Clinic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xavier F. Jimenez
Center for Comprehensive Pain Recovery, Neurological Institute, Cleveland Clinic; Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Tables

    • View popup
    TABLE 1

    Dosing and adverse effects of commonly prescribed tricyclic antidepressants

    Reuptake mechanismbAdverse effectsaInitial/maximum dosing (for MDD)
    SedationHypotensionSeizuresWeight gainCardiac
    Tertiary amine tricyclic antidepressants (TCAs)
    Amitriptyline5-HT > NE+++++++++++++25–75 mg/200 mg daily
    Clomipramine5-HT > NE++++++++++25 mg/250 mg daily
    Doxepin5-HT = NE++++++++++50–75 mg/300 mg nightly
    Imipramine5-HT = NE++++++++++++50–100 mg/200 mg daily
    Secondary amine TCAs
    DespiramineNE > 5-HT++++++100–200 mg/300 mg daily
    MaprotilineNE > 5-HT+++++++25–50 mg/225 mg nightly
    NortriptylineNE > 5-HT++++++25–50 mg/150 mg daily
    • ↵a Plus sign indicates potential severity of adverse effects.

    • ↵b Tertiary amine TCAs tend to preferentially inhibit serotonin reuptake, resulting in greater synaptic serotonin levels, whereas secondary amine TCAs tend to preferentially inhibit norepinephrine reuptake, resulting in greater synaptic norepinephrine levels.

    • MDD = major depressive disorder; NE = norepinephrine; 5-HT = serotonin

    • View popup
    TABLE 2

    Dosing guide for tricyclic antidepressants in conditions other than depression

    IndicationMedicationsInitial/maximum dosingDose escalationAdverse effect management
    Headache or migraineAmitriptyline10–25 mg/100 mg nightlyIndividualized: Increase by 10–25 mg every 5–14 days, assess for tolerability and adverse effects
    Amitriptyline side effects (dry mouth, orthostasis) often limit dose escalation above 100 mg; nortriptyline or maprotiline may be considered (better tolerated at higher doses)
    Dry mouth and secretions: Pilocarpine 5 mg 2–3/day
    Constipation: Stool softeners, eg, docusate sodium, senna glycoside
    Weight gain: Consider augmenting with metformin 500–1,000 mg/day or topiramate 50–100 mg/day
    Seizures, QT interval prolongation, active suicidal risk, orthostasis, or falls: Discontinue the agent
    Neuropathic painAmitriptyline25–50 mg/150 mg nightly (or divided into twice-daily doses if frequent pain or symptom flares)
    Chronic low back painAmitriptyline, maprotiline25–50 mg/150 mg nightly
    Fibromyalgia or chronic widespread painAmitriptyline, nortriptyline, maprotiline25–50 mg/150 mg nightly (or divided into twice-daily doses if frequent pain or symptom flares)
    Irritable bowel syndromeAmitriptyline, nortriptyline10–25 mg/100 mg nightly
    Cyclic vomiting syndromeAmitriptyline, nortriptyline25–50 mg/100 mg nightly
    Chronic pelvic pain, interstitial cystitis, nocturiaAmitriptyline, nortriptyline, imipramine10–25 mg/100 mg nightly
    InsomniaAmitriptyline, maprotiline, doxepin25–50 mg/150 mg nightly
PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 86 (12)
Cleveland Clinic Journal of Medicine
Vol. 86, Issue 12
1 Dec 2019
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Beyond depression: Other uses for tricyclic antidepressants
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Beyond depression: Other uses for tricyclic antidepressants
Joanne Schneider, Mary Patterson, Xavier F. Jimenez
Cleveland Clinic Journal of Medicine Dec 2019, 86 (12) 807-814; DOI: 10.3949/ccjm.86a.19005

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Beyond depression: Other uses for tricyclic antidepressants
Joanne Schneider, Mary Patterson, Xavier F. Jimenez
Cleveland Clinic Journal of Medicine Dec 2019, 86 (12) 807-814; DOI: 10.3949/ccjm.86a.19005
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • ABSTRACT
    • BRIEF HISTORY OF TRICYCLICS
    • TCA PHARMACOLOGY
    • MECHANISMS OF ACTION
    • POTENTIAL USES
    • ADVERSE EFFECTS
    • CONTRAINDICATIONS
    • OVERDOSE IS HIGHLY DANGEROUS
    • OFF-LABEL TCA MANAGEMENT
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • Off-label and oft-prescribed
  • PubMed
  • Google Scholar

Cited By...

  • Quantitative analysis of nortriptylines analgesic properties: a comparative systematic review and meta-analysis
  • Antidepressant drugs act by directly binding to TRKB neurotrophin receptors
  • Google Scholar

More in this TOC Section

  • Alpha-gal syndrome: Recognizing and managing a tick-bite–related meat allergy
  • Managing right ventricular failure in the setting of pulmonary embolism
  • Nociplastic pain: A practical guide to chronic pain management in the primary care setting
Show more Review

Similar Articles

Subjects

  • Drug Therapy
  • Gastroenterology
  • Mental Health
  • Neurology
  • Pain
  • Rheumatology
  • Sleep Medicine
  • Women's Health

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire